(Q38388047)

2 September 2017

1 reference

title

The baculovirus expression vector system: A commercial manufacturing platform for viral vaccines and gene therapy vectors (English)

1 reference

2 September 2017

0 references

Rachael S Felberbaum

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25800821%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

publication date

20 March 2015

1 reference

25800821

2 September 2017

published in

Biotechnology Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25800821%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

volume

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25800821%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25800821%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

702-714

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25800821%20AND%20SRC:MED&resulttype=core&format=json

Recombinant protein vaccines produced in insect cells

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Vaccines for viral and parasitic diseases produced with baculovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Production of recombinant proteins by microbes and higher organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

A fast track influenza virus vaccine produced in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Insect cell technology is a versatile and robust vaccine manufacturing platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Opportunities and challenges for the baculovirus expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Baculovirus-insect cell expression systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Baculovirus as a highly efficient expression vector in insect and mammalian cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

The complete DNA sequence of Autographa californica nuclear polyhedrosis virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Production of Human Beta Interferon in Insect Cells Infected with a Baculovirus Expression Vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

A Baculovirus Dual Expression Vector Derived from the Autographa Californica Nuclear Polyhedrosis Virus Polyhedrin and p10 Promoters: Co-expression of Two Influenza Virus Genes in Insect Cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Spontaneous excision of BAC vector sequences from bacmid-derived baculovirus expression vectors upon passage in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Screening of insect cell lines for the production of recombinant proteins and infectious virus in the baculovirus expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Traditional and new influenza vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Molecular mechanisms enhancing the proteome of influenza A viruses: an overview of recently discovered proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Mechanism of a decrease in potency for the recombinant influenza A virus hemagglutinin H3 antigen during storage

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Modifications of cysteine residues in the transmembrane and cytoplasmic domains of a recombinant hemagglutinin protein prevent cross-linked multimer formation and potency loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Pandemic novel 2009 H1N1 influenza: what have we learned?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Impact of influenza B lineage-level mismatch between trivalent seasonal influenza vaccines and circulating viruses, 1999-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Influenza vaccine: the challenge of antigenic drift.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Molecular and structural characterization of the L1 virus-like particles that are used as vaccine antigens in Cervarix™, the AS04-adjuvanted HPV-16 and -18 cervical cancer vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

A recombinant baculovirus-expressed S glycoprotein vaccine elicits high titers of SARS-associated coronavirus (SARS-CoV) neutralizing antibodies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

A designer hyper interleukin 11 (H11) is a biologically active cytokine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

A vaccine of L2 epitope repeats fused with a modified IgG1 Fc induced cross-neutralizing antibodies and protective immunity against divergent human papillomavirus types

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Baculovirus vector as an avian influenza vaccine: hemagglutinin expression and presentation augment the vaccine immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

PROVENGE (Sipuleucel-T) in prostate cancer: the first FDA-approved therapeutic cancer vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Efficient gene transfer into human hepatocytes by baculovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Baculovirus-mediated gene transfer into mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Arbovirus vaccines; opportunities for the baculovirus-insect cell expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Latent infection of a new alphanodavirus in an insect cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Identification of a novel rhabdovirus in Spodoptera frugiperda cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Mammalian stable expression of biotherapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Vaccine process technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Thirty years of baculovirus-insect cell protein expression: from dark horse to mainstream technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Baculovirus as versatile vectors for protein expression in insect and mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Transforming lepidopteran insect cells for improved protein processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

N-Glycosylation engineering of lepidopteran insect cells by the introduction of the beta1,4-N-acetylglucosaminyltransferase III gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

A transgenic insect cell line engineered to produce CMP-sialic acid and sialylated glycoproteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

SweetBac: a new approach for the production of mammalianised glycoproteins in insect cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Recombinant adeno-associated virus transduction and integration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

New developments in the use of gene therapy to treat Duchenne muscular dystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Analysis of AAV serotypes 1-9 mediated gene expression and tropism in mice after systemic injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Insect cells as a factory to produce adeno-associated virus type 2 vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

A simplified baculovirus-AAV expression vector system coupled with one-step affinity purification yields high-titer rAAV stocks from insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Improving adeno-associated vector yield in high density insect cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Successful production of pseudotyped rAAV vectors using a modified baculovirus expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Economized large-scale production of high yield of rAAV for gene therapy applications exploiting baculovirus expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Removal of empty capsids from type 1 adeno-associated virus vector stocks by anion-exchange chromatography potentiates transgene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Toward exascale production of recombinant adeno-associated virus for gene transfer applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Producing recombinant adeno-associated virus in foster cells: overcoming production limitations using a baculovirus-insect cell expression strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Large-scale production of recombinant adeno-associated viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Novel tools for production and purification of recombinant adenoassociated virus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Immune Responses to AAV-Vectors, the Glybera Example from Bench to Bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Safety profile of recombinant adeno-associated viral vectors: focus on alipogene tiparvovec (Glybera®).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Identification of sequence variants in genetic disease-causing genes using targeted next-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Current status of haemophilia gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Advances in AAV vector development for gene therapy in the retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Preclinical safety evaluation of AAV2-sFLT01- a gene therapy for age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Adeno-associated virus (AAV) gene therapy for neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Full-length dystrophin reconstitution with adeno-associated viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Recombinant trivalent influenza vaccine (flublok(®)): a review of its use in the prevention of seasonal influenza in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Global alert to avian influenza virus infection: from H5N1 to H7N9

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Receptor specificity and transmission of H2N2 subtype viruses isolated from the pandemic of 1957.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

A subunit vaccine candidate derived from a classic H5N1 avian influenza virus in China protects fowls and BALB/c mice from lethal challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Development of influenza H7N9 virus like particle (VLP) vaccine: homologous A/Anhui/1/2013 (H7N9) protection and heterologous A/chicken/Jalisco/CPA1/2012 (H7N3) cross-protection in vaccinated mice challenged with H7N9 virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Baculovirus-expressed influenza vaccine. A novel technology for safe and expeditious vaccine production for human use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Development of the vault particle as a platform technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Severe acute respiratory syndrome vs. the Middle East respiratory syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Porcine epidemic diarrhoea virus: a comprehensive review of molecular epidemiology, diagnosis, and vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

The SARS-CoV S glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Current advancements and potential strategies in the development of MERS-CoV vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Drug Targets for Rational Design against Emerging Coronaviruses

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2FBIOT.201400438

21 January 2018

12 December 2020

Baculovirus surface display of SARS coronavirus (SARS-CoV) spike protein and immunogenicity of the displayed protein in mice models

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Antigenic and immunogenic characterization of recombinant baculovirus-expressed severe acute respiratory syndrome coronavirus spike protein: implication for vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Immune responses against severe acute respiratory syndrome coronavirus induced by virus-like particles in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Virus-like particles of SARS-like coronavirus formed by membrane proteins from different origins demonstrate stimulating activity in human dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Vaccination of mice with recombinant baculovirus expressing spike or nucleocapsid protein of SARS-like coronavirus generates humoral and cellular immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Chimeric severe acute respiratory syndrome coronavirus (SARS-CoV) S glycoprotein and influenza matrix 1 efficiently form virus-like particles (VLPs) that protect mice against challenge with SARS-CoV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Assembly and immunogenicity of coronavirus-like particles carrying infectious bronchitis virus M and S proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Chikungunya at the door--déjà vu all over again?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Effective chikungunya virus-like particle vaccine produced in insect cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Chikungunya virus-like particles are more immunogenic in a lethal AG129 mouse model compared to glycoprotein E1 or E2 subunits

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Enhanced production of Chikungunya virus-like particles using a high-pH adapted spodoptera frugiperda insect cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Infectious Disease. Estimating the Ebola epidemic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Antibodies are necessary for rVSV/ZEBOV-GP-mediated protection against lethal Ebola virus challenge in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Easy expression of the C-terminal heavy chain domain of botulinum neurotoxin serotype A as a vaccine candidate using a bi-cistronic baculovirus system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Rapid immune responses to a botulinum neurotoxin Hc subunit vaccine through in vivo targeting to antigen-presenting cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Development of a recombinant toxin fragment vaccine for Clostridium difficile infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Recombinant antigens based on toxins A and B of Clostridium difficile that evoke a potent toxin-neutralising immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FBIOT.201400438

Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications.

21 January 2018

2 references

https://api.crossref.org/works/10.1002%2FBIOT.201400438

21 January 2018

12 December 2020

Pandemic influenza vaccine: characterization of A/California/07/2009 (H1N1) recombinant hemagglutinin protein and insights into H1N1 antigen stability

1 reference

12 December 2020

Baculovirus-mediated expression of bacterial genes in dipteran and mammalian cells

1 reference

12 December 2020

In Vitro Survey of Autographa californica Nuclear Polyhedrosis Virus Interaction with Nontarget Vertebrate Host Cells.

1 reference

12 December 2020

Influenza neuraminidase as a vaccine antigen.

1 reference

12 December 2020

A method for producing recombinant baculovirus expression vectors at high frequency.

1 reference

12 December 2020

Evaluation of the safety, reactogenicity and immunogenicity of FluBlok® trivalent recombinant baculovirus-expressed hemagglutinin influenza vaccine administered intramuscularly to healthy adults 50-64 years of age

1 reference

12 December 2020

Technology transfer and scale-up of the Flublok recombinant hemagglutinin (HA) influenza vaccine manufacturing process.

1 reference

12 December 2020

Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons > or =65 years old

1 reference

12 December 2020

The establishment of two cell lines from the insectspodoptera frugiperda (lepidoptera; noctuidae)

1 reference

12 December 2020

Middle East respiratory syndrome coronavirus: transmission and phylogenetic evolution

1 reference

12 December 2020

Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: a randomized, placebo-controlled trial

1 reference

12 December 2020

Gypsy endogenous retrovirus maintains potential infectivity in several species of Drosophilids

1 reference

12 December 2020

Advances in universal influenza virus vaccine design and antibody mediated therapies based on conserved regions of the hemagglutinin.

1 reference

12 December 2020

Identifiers

DOI

10.1002/BIOT.201400438

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25800821%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25800821%20AND%20SRC:MED&resulttype=core&format=json

7 June 2020

25800821

1 reference